Integral Derivatives’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$216K Sell
3,600
-9,200
-72% -$554K 0.01% 602
2017
Q4
$730K Sell
12,800
-10,900
-46% -$604K 0.01% 590
2017
Q3
$1.26M Buy
23,700
+9,800
+71% +$492K 0.02% 417
2017
Q2
$676K Buy
13,900
+500
+4% +$22.6K 0.01% 609
2017
Q1
$595K Buy
+13,400
New +$579K 0.01% 695
2016
Q4
Sell
-17,600
Closed -$744K 1110
2016
Q3
$744K Buy
17,600
+4,900
+39% +$210K 0.02% 511
2016
Q2
$499K Buy
+12,700
New +$506K 0.01% 592
2014
Q4
Sell
-15,500
Closed -$645K 1350
2014
Q3
$645K Buy
+15,500
New +$656K 0.01% 883
2014
Q1
Sell
-17,100
Closed -$655K 1280
2013
Q4
$655K Buy
+17,100
New +$630K 0.01% 951

Other funds holding ABT

Integral Derivatives's ABT Position: Q3 2017 in Review

Integral Derivatives sold out of Abbott (ABT) in Q3 2017, closing a stake of 4,519 shares — an estimated $227K sold.

Integral Derivatives first reported a position in ABT in Q4 2013 and held it in 4 quarters. The position peaked at $1.73M in Q4 2013. 1,597 funds tracked by Wall St. Rank hold ABT as of Q3 2017.

  • Integral Derivatives reported no remaining Abbott position as of Q3 2017 after selling out during the quarter.
  • Integral Derivatives sold 4,519 Abbott shares in Q3 2017, an estimated $227K.
  • Integral Derivatives first reported a position in Abbott in Q4 2013 and held it in 4 quarters.
  • Integral Derivatives's Abbott position peaked at $1.73M in Q4 2013.
  • 1,597 funds tracked by Wall St. Rank held Abbott as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.